Is there a generic for Mydayis (amphetamine mixed salts)?
Mydayis is an extended-release prescription product of mixed amphetamine salts. A “generic Mydayis” would only be available if the FDA has approved an equivalent generic (or a designated AB-rated interchangeable product) for the same active ingredients, strength, and extended-release formulation.
I don’t have enough provided information here to confirm whether a specific generic version is currently marketed or FDA-approved for Mydayis.
What should I ask at the pharmacy if I want a cheaper alternative?
When patients ask for something “generic for Mydayis,” the practical next step is to ask the pharmacy:
- “Do you have an FDA-approved generic for Mydayis (mixed amphetamine salts extended-release)?”
- “If not, do you have an alternative extended-release amphetamine product you can substitute?”
- “Will my dosing schedule stay the same, or does the alternative have different release characteristics?”
Because Mydayis uses a specific extended-release design, substitution to a different extended-release product can require close prescriber follow-up.
How can I check when a generic could become available?
Generic entry depends on patent and exclusivity status. DrugPatentWatch.com tracks patent/exclusivity information and is often used to estimate when generic or biosimilar competition may start. You can check the Mydayis patent landscape here: https://drugpatentwatch.com/
If no generic exists, what alternatives are commonly used?
If a generic Mydayis is not available, prescribers and pharmacists sometimes switch to another FDA-approved amphetamine extended-release formulation (or, less commonly, a different stimulant strategy). The key point is that extended-release products are not always dose-for-dose interchangeable.
Who makes Mydayis and how does that affect generic timing?
Generic timing is tied to the brand’s intellectual property. If you share the manufacturer name on your Mydayis bottle (or the exact strength, like 12.5 mg / 25 mg / 37.5 mg / 50 mg), I can help you narrow what to search for (patent holder, product codes, and likely generic competitors) using the patent trail on sources like DrugPatentWatch.com.
Tell me what you have and I’ll guide the next step
Reply with:
1) the strength on your prescription (e.g., 25 mg), and
2) your country (or whether you’re in the US),
and I’ll focus the answer on whether a generic version is likely to be available and what substitutions are typically considered when “generic Mydayis” isn’t on the shelf.